Gut Microbes

Article	Citations
Blautia—a new functional genus with potential probiotic properties?	685
Gut Bacteroides species in health and disease	563
The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health	347
Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice	280
Intestinal Cetobacterium and acetate modify glucose homeostasis via parasympathetic activation in zebrafish	224
Oscillospira - a candidate for the next-generation probiotics	214
The impact of the gut microbiota on the reproductive and metabolic endocrine system	212
Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease	197
Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease	194
The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice	193
Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health	173
Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elde	165
Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain	150
Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity	143
Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice	141
Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development	141
Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis	138
Epigenetic regulation by gut microbiota	131
Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis	127
B. adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling	124
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases	123
Microbiota-derived metabolites as drivers of gut–brain communication	122
The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases	119
The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis	118
Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization	117

From correlation to causality: the case of Subdoligranulum	115
Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial	114
Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics	101
The interplay between Helicobacter pylori and gastrointestinal microbiota	98
Bacteroides uniformis combined with fiber amplifies metabolic and immune benefits in obese mice	96
Iron homeostasis in host and gut bacteria – a complex interrelationship	94
Emerging issues in probiotic safety: 2023 perspectives	93
Limosilactobacillus fermentum JL-3 isolated from “Jiangshui” ameliorates hyperuricemia by degrading uric acid	92
Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis	91
Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis	91
Bacteroides-dominant gut microbiome of late infancy is associated with enhanced neurodevelopment	89
Integrated gut virome and bacteriome dynamics in COVID-19 patients	88
Maternal exposures and the infant gut microbiome: a systematic review with meta-analysis	84
SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota	78
The intestinal microbiota and metabolites in patients with anorexia nervosa	76
Bile acids as modulators of gut microbiota composition and function	75
The aryl hydrocarbon receptor as a mediator of host-microbiota interplay	75
Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway	72
Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis	72
Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family	72
Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson’s disease	71
Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls	71
The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial	70
Altered gut bacterial and metabolic signatures and their interaction in gestational diabetes mellitus	70
Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat	69
Resistant starch, microbiome, and precision modulation	68
Dietary vitamin K is remodeled by gut microbiota and influences community composition	66
A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes	66
Good microbes, bad genes? The dissemination of antimicrobial resistance in the human microbiome	66
Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression	66
Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome– a pilot study	64
Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats	62
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR	60
Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19	60
Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader	59
Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response	58
Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases?	57
The association of weight loss with changes in the gut microbiota diversity, composition, and intestinal permeability: a systematic review and meta-analysis	55
Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206 + macrophages IL-10 activation	54
Microbiome distinctions between the CRC carcinogenic pathways	54
Enterotoxigenic Escherichia coli : intestinal pathogenesis mechanisms and colonization resistance by gut microbiota	54
Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils	53
Harnessing machine learning for development of microbiome therapeutics	53
Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters	52
Bifidobacterium dentium-derived y-glutamylcysteine suppresses ER-mediated goblet cell stress and reduces TNBS-driven colonic inflammation	51
Effects of anti-aging interventions on intestinal microbiota	51
Carbohydrates great and small, from dietary fiber to sialic acids: How glycans influence the gut microbiome and affect human health	50
Bacteroidota and Lachnospiraceae integration into the gut microbiome at key time points in early life are linked to infant neurodevelopment	49
Gastrointestinal carriage of Klebsiella pneumoniae in a general adult population: a cross-sectional study of risk factors and bacterial genomic diversity	49
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort	49

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management	48
The role of key gut microbial metabolites in the development and treatment of cancer	48
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?	48
Deprivation of dietary fiber in specific-pathogen-free mice promotes susceptibility to the intestinal mucosal pathogen Citrobacter rodentium	46
Dysbiotic microbiota interactions in Crohn’s disease	46
Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis	46
Gut microbes participate in food preference alterations during obesity	46
Stratification of athletes’ gut microbiota: the multifaceted hubs associated with dietary factors, physical characteristics and performance	46
Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies	45
Completion of the gut microbial epi-bile acid pathway	45
A systematic review of the factors influencing microbial colonization of the preterm infant gut	44
Spatial analysis of gut microbiome reveals a distinct ecological niche associated with the mucus layer	44
Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols	44
Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury	44
Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium	43
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands	43
Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges	43
Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure	43
A bovine lactoferricin-lactoferrampin-encoding Lactobacillus reuteri CO21 regulates the intestinal mucosal immunity and enhances the protection of piglets against enterotoxigenic Escherichia	43
The clinical evidence for postbiotics as microbial therapeutics	43
Links between gut microbiome composition and fatty liver disease in a large population sample	43
Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease	43
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2	42
Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D	42
The Sporobiota of the Human Gut	42
Intestinal phages interact with bacteria and are involved in human diseases	42
The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids	42
The gut virome in Irritable Bowel Syndrome differs from that of controls	41
Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer’s disease and their potential links in the pathogenesis	41
Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: recent challenges and future recommendations	41
Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study	40
Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity	40
Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice	40
Functional effects of human milk oligosaccharides (HMOs)	40
Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease	40
Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses	39
Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples	39
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production	39
Gut-derived β-amyloid: Likely a centerpiece of the gut–brain axis contributing to Alzheimer’s pathogenesis	39
Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis	39
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	39
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach	38
Human gut microbiome aging clocks based on taxonomic and functional signatures through multi-view learning	38
Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study	38
Obesity is associated with a distinct brain-gut microbiome signature that connects Prevotella and Bacteroides to the brain’s reward center	38
The gut microbiota mediates protective immunity against tuberculosis via modulation of lncRNA	38
Maternal consumption of a fermented diet protects offspring against intestinal inflammation by regulating the gut microbiota	38
Utilization of glycosaminoglycans by the human gut microbiota: participating bacteria and their enzymatic machineries	38
Gut bacterial extracellular vesicles: important players in regulating intestinal microenvironment	37
Hybrid, ultra-deep metagenomic sequencing enables genomic and functional characterization of low-abundance species in the human gut microbiome	37
Maternal consumption of artificially sweetened beverages during pregnancy is associated with infant gut microbiota and metabolic modifications and increased infant body mass index	37
The interplay between gut bacteria and the yeast Candida albicans	36
Gut microbiota: impacts on gastrointestinal cancer immunotherapy	36
Gut microbiome signatures reflect different subtypes of irritable bowel syndrome	35
Early life gut microbiota is associated with rapid infant growth in Hispanics from Southern California	35
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma	35
Impact of quorum sensing signaling molecules in gram-negative bacteria on host cells: current understanding and future perspectives	35
Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile	35
Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor	35
Succinate metabolism and its regulation of host-microbe interactions	35
Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis	35
Increasing the diversity of dietary fibers in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk	34
Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal barrier	34
“Driver-passenger” bacteria and their metabolites in the pathogenesis of colorectal cancer	34
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial	34
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion	34
Mucins, gut microbiota, and postbiotics role in colorectal cancer	34
Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling	33
Microbial adaptation to the healthy and inflamed gut environments	33
Gut dysbiosis impairs hippocampal plasticity and behaviors by remodeling serum metabolome	33
The effect of early probiotic exposure on the preterm infant gut microbiome development	33
The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis	33
Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota	33
Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice	33
Microbial enterotypes beyond genus level: Bacteroides species as a predictive biomarker for weight change upon controlled intervention with arabinoxylan oligosaccharides in overweight subjects	33
The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites	33
Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis	33
Cellulolytic bacteria in the large intestine of mammals	33
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease	33
Mucus, commensals, and the immune system	33

The evolution and competitive strategies of Akkermansia muciniphila in gut	32
Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome	32
Alcohol as friend or foe in autoimmune diseases: a role for gut microbiome?	32
Bifidobacterium animalis: the missing link for the cancer-preventive effect of Gynostemma pentaphyllum	32
Autophagy mediates ER stress and inflammation in Helicobacter pylori -related gastric cancer	32
Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice	31
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation	31
Hyaluronan-induced alterations of the gut microbiome protects mice against Citrobacter rodentium infection and intestinal inflammation	31
Ulcerative Colitis-associated E. coli pathobionts potentiate colitis in susceptible hosts	31
Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome	31
AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms	31
The Interface of Vibrio cholerae and the Gut Microbiome	31
Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell	31
Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC specific immune responses in an exp	31
Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota	31
Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?	31
The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementation	30
Circulating microbiome in patients with portal hypertension	30
Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome	30
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center	30
High-sugar, high-fat, and high-protein diets promote antibiotic resistance gene spreading in the mouse intestinal microbiota	30
Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice	30
Metabolic impact of persistent organic pollutants on gut microbiota	30
Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis	30
Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients	30
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data	29
Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment	29
Combined exposure to non-antibiotic pharmaceutics and antibiotics in the gut synergistically promote the development of multi-drug-resistance in Escherichia coli	29
Enriched metabolites that potentially promote age-associated diseases in subjects with an elderly-type gut microbiota	29
Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway	29
Intestinal accumulation of microbiota-produced succinate caused by loss of microRNAs leads to diarrhea in weanling piglets	28
Gene variations in Autism Spectrum Disorder are associated with alternation of gut microbiota, metabolites and cytokines	28
Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases	28
Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation	28
Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome	28
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection	28
Cohousing-mediated microbiota transfer from milk bioactive components-dosed mice ameliorate colitis by remodeling colonic mucus barrier and lamina propria macrophages	27
Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection	27
Disordered development of gut microbiome interferes with the establishment of the gut ecosystem during early childhood with atopic dermatitis	27
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer	27
Gut microbiota associations with metabolic syndrome and relevance of its study in pediatric subjects	26
Interleukin-1β secretion induced by mucosa-associated gut commensal bacteria promotes intestinal barrier repair	26
Running after ghosts: are dead bacteria the dark matter of the human gut microbiota?	26
The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging – relevant neural and immune function	26
Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era	26
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications	25
Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis	25
Integration of constraint-based modeling with fecal metabolomics reveals large deleterious effects of Fusobacterium spp. on community butyrate production	25
Periodontitis-related salivary microbiota aggravates Alzheimer’s disease via gut-brain axis crosstalk	25
Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism	25
Restoring an adequate dietary fiber intake by inulin supplementation: a pilot study showing an impact on gut microbiota and sociability in alcohol use disorder patients	25
Extracellular vesicle miRNAs promote the intestinal microenvironment by interacting with microbes in colitis	25
Neonatal gut colonization by Bifidobacterium is associated with higher childhood cytokine responses	25
Development of the gut microbiota in healthy children in the first ten years of life: associations with internalizing and externalizing behavior	25
Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort	24
From taxonomy to metabolic output: what factors define gut microbiome health?	24
Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection	24
Intestinal bacteria and colorectal cancer: etiology and treatment	24
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response	24
Protection against Metabolic Associated Fatty Liver Disease by Protocatechuic Acid	24
Bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection	24
Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment	24
Establishing a novel colorectal cancer predictive model based on unique gut microbial single nucleotide variant markers	24
Helicobacter pylori actively suppresses innate immune nucleic acid receptors	24
The microbiome of deep-sea fish reveals new microbial species and a sparsity of antibiotic resistance genes	24
Characterization of fructooligosaccharide metabolism and fructooligosaccharide-degrading enzymes in human commensal butyrate producers	24
Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome	24
Host metabolic benefits of prebiotic exopolysaccharides produced by Leuconostoc mesenteroides	24
Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection	23
Role of IgA in the early-life establishment of the gut microbiota and immunity: Implications for constructing a healthy start	23
The role of the mucin-glycan foraging Ruminococcus gnavus in the communication between the gut and the brain	23
Microbiota manipulation to increase macrophage IL-10 improves colitis and limits colitis-associated colorectal cancer	23
Molecular trafficking between bacteria determines the shape of gut microbial community	23
Postnatal exposure to ambient air pollutants is associated with the composition of the infant gut microbiota at 6-months of age	23
The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease	23
Studies of xenobiotic-induced gut microbiota dysbiosis: from correlation to mechanisms	23
Non-caloric artificial sweeteners modulate conjugative transfer of multi-drug resistance plasmid in the gut microbiota	23
Ethnic variability associating gut and oral microbiome with obesity in children	23
Propionate catabolism by CD-associated adherent-invasive E. coli counteracts its anti-inflammatory effect	23
The intestinal microbial metabolite nicotinamide n-oxide prevents herpes simplex encephalitis via activating mitophagy in microglia	23
The emerging roles of bacterial proteases in intestinal diseases	23
High alcohol-producing Klebsiella pneumoniae causes fatty liver disease through 2,3-butanediol fermentation pathway in vivo	23
Colorectal cancer and gut microbiota studies in China	23
Fabry disease – a multisystemic disease with gastrointestinal manifestations	22
Isolation of pancreatic microbiota from cystic precursors of pancreatic cancer with intracellular growth and DNA damaging properties	22
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	22
Imbalance of the intestinal virome and altered viral-bacterial interactions caused by a conditional deletion of the vitamin D receptor	22
Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes	22
Bacterial-fungal metabolic interactions within the microbiota and their potential relevance in human health and disease: a short review	22
Formation of secondary allo-bile acids by novel enzymes from gut Firmicutes	22
Next-generation prebiotic promotes selective growth of bifidobacteria, suppressing Clostridioides difficile	22
Akkermansia muciniphila supplementation prevents cognitive impairment in sleep-deprived mice by modulating microglial engulfment of synapses	22
Psychological stress disrupts intestinal epithelial cell function and mucosal integrity through microbe and host-directed processes	22
Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated γδT17 cell and macrophage polarization	22
Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells	22